人体微生物组在辅助2型糖尿病诊疗中的潜在应用

doi:10.7518/hxkq.2019.05.020

华西口腔医学杂志 ›› 2019, Vol. 37 ›› Issue (5): 556-562.doi: 10.7518/hxkq.2019.05.020

人体微生物组在辅助2型糖尿病诊疗中的潜在应用

刘云坤,徐欣,周学东()

口腔疾病研究国家重点实验室国家口腔疾病临床医学研究中心四川大学华西口腔医院牙体牙髓病科,成都 610041

收稿日期:2019-04-15 修回日期:2019-07-09 出版日期:2019-10-01 发布日期:2019-10-15
通讯作者: 周学东 E-mail:zhouxd@scu.edu.cn
作者简介:刘云坤,硕士,E-mail：121438062@qq.com
基金资助:
国家自然科学基金(81430011);国家自然科学基金(81670978);四川省科技厅重大前沿项目(2016JY0006)

Potential application of human microbiomes in the diagnosis and treatment of type 2 diabetes mellitus

Liu Yunkun,Xu Xin,Zhou Xuedong()

State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Dept. of Cariology and Endodontics, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China

Received:2019-04-15 Revised:2019-07-09 Online:2019-10-01 Published:2019-10-15
Contact: Xuedong Zhou E-mail:zhouxd@scu.edu.cn
Supported by:
The National Natural Science Foundation of China(81430011);The National Natural Science Foundation of China(81670978);The Key Project for Frontier Research of Science and Technology Department of Sichuan Province(2016JY0006)

摘要/Abstract

摘要：

人体微生物组是指人体体表及内部的微生物的遗传信息总和,与人类健康与疾病状态存在密切关系。口腔和肠道微生物是最具多样化的微生物群落,两者可以交互影响,在疾病发生发展过程中共同发挥作用,并可以实时反映机体的健康与疾病状态。2型糖尿病是由遗传和环境因素引起的代谢紊乱,最近的研究指出微生物与糖尿病存在关联。本文结合近期的研究进展,就2型糖尿病患者口腔微生物和肠道微生物的特征进行综述,有望为探索基于微生物组特征的2型糖尿病风险预测、诊断和预后预测的疾病模型的建立提供参考依据。

关键词: 2型糖尿病, 口腔微生物组, 肠道微生物组, 精准医疗

Abstract:

Human microbiome refers to the total microorganism genetic information of human body surface and internal, which is closely related to human health and disease. Oral and gut microbiomes are the most diverse microbial communities, which can interact and play a role in the development of the disease, and can reflect the health and disease state in real time. Type 2 diabetes mellitus is a metabolic disorder caused by both genetic and environmental factors. Recent research has shown a link between microbes and diabetes. This article reviewed the latest research on the changes of oral and gut microbiomes in type 2 diabetes mellitus patients, which expects to provide a reference for exploring the development of the disease model for prediction, diagnosis and prognosis of type 2 diabetes mellitus based on human microbiome characteristics.

Key words: type 2 diabetes mellitus, oral microbiome, gut microbiome, precision medicine

中图分类号:

刘云坤,徐欣,周学东. 人体微生物组在辅助2型糖尿病诊疗中的潜在应用[J]. 华西口腔医学杂志, 2019, 37(5): 556-562.

Liu Yunkun,Xu Xin,Zhou Xuedong. Potential application of human microbiomes in the diagnosis and treatment of type 2 diabetes mellitus[J]. West China Journal of Stomatology, 2019, 37(5): 556-562.

参考文献 69

[1]	American Diabetes Association . Diagnosis and classification of diabetes mellitus[J]. Diabetes Care, 2014,37(Suppl 1):S81-S90.
[2]	Ogurtsova K, da Rocha Fernandes JD, Huang Y , et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040[J]. Diabetes Res Clin Pract, 2017,128:40-50.
[3]	Xu Y, Wang L, He J , et al. Prevalence and control of diabetes in Chinese adults[J]. Jama, 2013,310(9):948-959.
[4]	American Diabetes Association . Classification and diagnosis of diabetes: standards of medical care in diabetes-2018[J]. Diabetes Care, 2018,41(Suppl 1):S13-S27.
[5]	熊燕, 林瑗 . 糖尿病并发症的研究进展[J]. 中国医师杂志, 2017,19(10):1441-1449.
	Xiong Y, Lin A . Research progress of diabetic complications[J]. J Chin Phys, 2017,19(10):1441-1449.
[6]	Chatterjee S, Davies MJ, Heller S , et al. Diabetes structured self-management education programmes: a narrative review and current innovations[J]. Lancet Diabetes Endocrinol, 2018,6(2):130-142.
[7]	Baig S . Reviewing personal bacteria-the human microbiome project[J]. J Coll Physicians Surg Pak, 2012,22(1):3-4.
[8]	程兴群, 徐欣, 周学东 . 口腔微生物与肠道微生物的关系[J]. 华西口腔医学杂志, 2017,35(3):322-327.
	Cheng XQ, Xu X, Zhou XD . Relationship between oral and gut microbes[J]. West China J Stomatol, 2017,35(3):322-327.
[9]	Sender R, Fuchs S, Milo R . Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans[J]. Cell, 2016,164(3):337-340.
[10]	Turnbaugh PJ, Ley RE, Hamady M , et al. The human microbiome project[J]. Nature, 2007,449(7164):804-810.
[11]	Dewhirst FE, Chen T, Izard J , et al. The human oral microbiome[J]. J Bacteriol, 2010,192(19):5002-5017.
[12]	Wade WG . The oral microbiome in health and disease[J]. Pharmacol Res, 2013,69(1):137-143.
[13]	Fábián TK, Fejérdy P, Csermely P . Salivary genomics, transcriptomics and proteomics: the emerging concept of the oral ecosystem and their use in the early diagnosis of cancer and other diseases[J]. Curr Genomics, 2008,9(1):11-21.
[14]	Costea PI, Hildebrand F, Arumugam M , et al. Enterotypes in the landscape of gut microbial community composition[J]. Nat Microbiol, 2018,3(1):8-16.
[15]	Hsiao WW, Fraser-Liggett CM . Human Microbiome Project: paving the way to a better understanding of ourselves and our microbes[J]. Drug Discov Today, 2009,14(7/8):331-333.
[16]	Knight R, Callewaert C, Marotz C , et al. The microbiome and human biology[J]. Annu Rev Genomics Human Genet, 2017,18(1):65-86.
[17]	Integrative HMP (iHMP) Research Network Consortium. The Integrative Human Microbiome Project: dynamic analysis of microbiome-host omics profiles during periods of human health and disease[J]. Cell Host Microbe, 2014,16(3):276-289.
[18]	Flemer B, Warren RD, Barrett MP , et al. The oral microbiota in colorectal cancer is distinctive and predictive[J]. Gut, 2018,67(8):1454-1463.
[19]	Preshaw PM, Alba AL, Herrera D , et al. Periodontitis and diabetes: a two-way relationship[J]. Diabetologia, 2012,55(1):21-31.
[20]	Indurkar MS, Maurya AS, Indurkar S . Oral manifestations of diabetes[J]. Clin Diabetes, 2016,34(1):54-57.
[21]	Taylor JJ, Preshaw PM, Lalla E . A review of the evidence for pathogenic mechanisms that may link periodontitis and diabetes[J]. J Periodontol, 2013,84(4 Suppl):S113-S134.
[22]	Chee B, Park B, Bartold PM . Periodontitis and type Ⅱ diabetes: a two-way relationship[J]. Int J Evid Based Healthc, 2013,11(4):317-329.
[23]	Blasco-Baque V, Garidou L, Pomié C , et al. Periodontitis induced by Porphyromonas gingivalis drives periodontal microbiota dysbiosis and insulin resistance via an impaired adaptive immune response[J]. Gut, 2017,66(5):872-885.
[24]	Polak D, Shapira L . An update on the evidence for pathogenic mechanisms that may link periodontitis and diabetes[J]. J Clin Periodontol, 2018,45(2):150-166.
[25]	Teeuw WJ, Gerdes VE, Loos BG . Effect of periodontal treatment on glycemic control of diabetic patients: a systematic review and meta-analysis[J]. Diabetes Care, 2010,33(2):421-427.
[26]	Tremaroli V, Bäckhed F . Functional interactions between the gut microbiota and host metabolism[J]. Nature, 2012,489(7415):242-249.
[27]	Tolhurst G, Heffron H, Lam YS , et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2[J]. Diabetes, 2012,61(2):364-371.
[28]	Larraufie P, Martin-Gallausiaux C, Lapaque N , et al. SCFAs strongly stimulate PYY production in human enteroendocrine cells[J]. Sci Rep, 2018,8(1):74.
[29]	Gomes AC, Bueno AA, de Souza RG , et al. Gut microbiota, probiotics and diabetes[J]. Nutr J, 2014,13:60.
[30]	Tilg H, Moschen AR . Microbiota and diabetes: an evolving relationship[J]. Gut, 2014,63(9):1513-1521.
[31]	Han JL, Lin HL . Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective[J]. World J Gastroenterol, 2014,20(47):17737-17745.
[32]	Pedersen HK, Gudmundsdottir V, Nielsen HB , et al. Human gut microbes impact host serum metabolome and insulin sensitivity[J]. Nature, 2016,535(7612):376-381.
[33]	Jang C, Oh SF, Wada S , et al. A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance[J]. Nat Med, 2016,22(4):421-426.
[34]	Lynch CJ, Adams SH . Branched-chain amino acids in metabolic signalling and insulin resistance[J]. Nat Rev Endocrinol, 2014,10(12):723-736.
[35]	Mahendran Y, Jonsson A, Have CT , et al. Genetic evidence of a causal effect of insulin resistance on branched-chain amino acid levels[J]. Diabetologia, 2017,60(5):873-878.
[36]	Mithieux G . Does Akkermansia muciniphila play a role in type 1 diabetes[J]. Gut, 2018,67(8):1373-1374.
[37]	周学东, 徐健, 施文元 . 人类口腔微生物组学研究: 现状、挑战及机遇[J]. 微生物学报, 2017,57(6):806-821. doi: 10.13343/j.cnki.wsxb.20170063
	Zhou XD, Xu J, Shi WY . Human oral microbiome: progress, challenge and opportunity[J]. Acta Microbiol Sin, 2017,57(6):806-821. doi: 10.13343/j.cnki.wsxb.20170063
[38]	Teng F, Yang F, Huang S , et al. Prediction of early childhood caries via spatial-temporal variations of oral microbiota[J]. Cell Host Microbe, 2015,18(3):296-306.
[39]	Huang S, Li R, Zeng X , et al. Predictive modeling of gingivitis severity and susceptibility via oral microbiota[J]. ISME J, 2014,8(9):1768-1780.
[40]	Zhang X, Zhang D, Jia H , et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment[J]. Nat Med, 2015,21(8):895-905.
[41]	Guo Z, Zhang J, Wang Z , et al. Intestinal microbiota distinguish gout patients from healthy humans[J]. Sci Rep, 2016,6:20602.
[42]	Zhang Y, Sun J, Lin CC , et al. The emerging landscape of salivary diagnostics[J]. Periodontol 2000, 2016,70(1):38-52.
[43]	Anbalagan R, Srikanth P, Mani M , et al. Next generation sequencing of oral microbiota in Type 2 diabetes mellitus prior to and after neem stick usage and correlation with serum monocyte chemoattractant-1[J]. Diabetes Res Clin Pract, 2017,130:204-210.
[44]	李宗泽, 赵泽, 张文菲 , 等. 16S核糖体DNA Amplicon测序法分析2型糖尿病患者口腔微生物多样性[J]. 转化医学杂志, 2017,6(3):151-156.
	Li ZZ, Zhao Z, Zhang WF , et al. Aanlysis of oral microbial diversity in patients with type 2 diabetes mellitus by 16S ribosome DNA amplicon sequencing[J]. Translational Med J, 2017,6(3):151-156.
[45]	Long J, Cai Q, Steinwandel M , et al. Association of oral microbiome with type 2 diabetes risk[J]. J Periodontal Res, 2017,52(3):636-643.
[46]	Hintao J, Teanpaisan R, Chongsuvivatwong V , et al. The microbiological profiles of saliva, supragingival and subgingival plaque and dental caries in adults with and without type 2 diabetes mellitus[J]. Oral Microbiol Immunol, 2007,22(3):175-181.
[47]	Kampoo K, Teanpaisan R, Ledder RG , et al. Oral bacterial communities in individuals with type 2 diabetes who live in southern Thailand[J]. Appl Environ Microbiol, 2014,80(2):662-671.
[48]	Zhou M, Rong R, Munro D , et al. Investigation of the effect of type 2 diabetes mellitus on subgingival plaque microbiota by high-throughput 16S rDNA pyrosequencing[J]. PLoS One, 2013,8(4):e61516.
[49]	Casarin RC, Barbagallo A, Meulman T , et al. Subgingival biodiversity in subjects with uncontrolled type-2 diabetes and chronic periodontitis[J]. J Periodont Res, 2013,48(1):30-36.
[50]	Ebersole JL, Holt SC, Hansard R , et al. Microbiologic and immunologic characteristics of periodontal disease in Hispanic Americans with type 2 diabetes[J]. J Periodontol, 2008,79(4):637-646.
[51]	Bissong MEA, Fon PN, Kamga FHL , et al. Microbiological profile of oral infections in diabetic patients and non-diabetic controls in Southwest, Cameroon[J]. African J Clin Experimental Microbiology, 2014,15(3):138-143.
[52]	Goodson JM, Hartman ML, Shi P , et al. The salivary microbiome is altered in the presence of a high salivary glucose concentration[J]. PLoS One, 2017,12(3):e0170437.
[53]	Faith JJ, Guruge JL, Charbonneau M , et al. The long-term stability of the human gut microbiota[J]. Science, 2013,341(6141):1237439.
[54]	Muñoz-Garach A, Diaz-Perdigones C, Tinahones FJ . Gut microbiota and type 2 diabetes mellitus[J]. Endocrinol Nutr, 2016,63(10):560-568.
[55]	Lê KA, Li Y, Xu XJ , et al. Alterations in fecal Lactobacillus and Bifidobacterium species in type 2 diabetic patients in Southern China population[J]. Front Physiol, 2013,3:496.
[56]	Karlsson FH, Tremaroli V, Nookaew I , et al. Gut metagenome in European women with normal, impaired and diabetic glucose control[J]. Nature, 2013,498(7452):99-103.
[57]	Clemente JC, Ursell LK, Parfrey LW , et al. The impact of the gut microbiota on human health: an integrative view[J]. Cell, 2012,148(6):1258-1270.
[58]	Sedighi M, Razavi S, Navab-Moghadam F , et al. Comparison of gut microbiota in adult patients with type 2 diabetes and healthy individuals[J]. Microb Pathog, 2017,111:362-369.
[59]	Allin KH, Tremaroli V, Caesar R , et al. Aberrant intestinal microbiota in individuals with prediabetes[J]. Diabetologia, 2018,61(4):810-820.
[60]	Lambeth SM, Carson T, Lowe J , et al. Composition, diversity and abundance of gut microbiome in prediabetes and type 2 diabetes[J]. J Diabetes Obes, 2015,2(3):1-7.
[61]	Zhang X, Shen D, Fang Z , et al. Human gut microbiota changes reveal the progression of glucose intolerance[J]. PLoS One, 2013,8(8):e71108.
[62]	Qin J, Li Y, Cai Z , et al. A metagenome-wide association study of gut microbiota in type 2 diabetes[J]. Nature, 2012,490(7418):55-60.
[63]	American Diabetes Association . Pharmacologic approaches to glycemic treatment: Standards of Medical Care in Diabetes-2018[J]. Diabetes Care, 2018,41(Suppl 1):S73-S85.
[64]	Wu H, Esteve E, Tremaroli V , et al. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug[J]. Nat Med, 2017,23(7):850-858.
[65]	Cabreiro F . Metformin joins forces with microbes[J]. Cell Host Microbe, 2016,19(1):1-3.
[66]	Forslund K, Hildebrand F, Nielsen T , et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota[J]. Nature, 2015,528(7581):262-266.
[67]	de la Cuesta-Zuluaga J, Mueller NT, Corrales-Agudelo V , et al. Metformin is associated with higher relative abundance of mucin-degrading akkermansia muciniphila and several short-chain fatty acid-producing microbiota in the gut[J]. Diabetes Care, 2017,40(1):54-62.
[68]	Montandon SA, Jornayvaz FR . Effects of antidiabetic drugs on gut microbiota composition[J]. Genes(Basel), 2017, 8(10). pii: E250. doi: 10.3390/genes8100250.
[69]	Sato J, Kanazawa A, Watada H . Type 2 diabetes and bacteremia[J]. Ann Nutr Metab, 2017,71(Suppl 1):17-22.

人体微生物组在辅助2型糖尿病诊疗中的潜在应用

Potential application of human microbiomes in the diagnosis and treatment of type 2 diabetes mellitus

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 69

相关文章 12

编辑推荐

Metrics

本文评价

[1]	张彦表, 魏美容, 夏天永, 尹文婷, 毛淑梅. 2型糖尿病患者血清半乳糖凝聚素-3水平与牙周炎的相关性研究[J]. 华西口腔医学杂志, 2023, 41(6): 653-661.
[2]	王亚楠, 吴旋, 贾婷婷, 冯瑶, 刘世岳, 徐欣, 张东姣. 2型糖尿病对小鼠下颌骨骨再生及辅助性T细胞17、调节性T细胞相关因子表达的影响[J]. 华西口腔医学杂志, 2021, 39(6): 642-650.
[3]	廖锋,刘瑶,刘航航,胡建,赵爽,杨世茂. 当归多糖对高糖状态下大鼠骨髓间充质干细胞成骨向分化的影响[J]. 华西口腔医学杂志, 2019, 37(2): 193-199.
[4]	程兴群,周学东,徐欣. 唾液的诊断应用研究[J]. 华西口腔医学杂志, 2016, 34(6): 647-653.
[5]	郭斌梁倩倩吕岩付敏陈媛媛袁一芳李颖超. Er: YAG激光对2型糖尿病相关性牙周炎患者龈下菌群动态变化的研究[J]. 华西口腔医学杂志, 2014, 32(2): 171-176.
[6]	袁堂霞张彦表周云王凡涛王峰. 牙周非手术治疗对2型糖尿病伴牙周炎患者糖化血红蛋白A1c和血清可溶性细胞间黏附分子-1的影响[J]. 华西口腔医学杂志, 2013, 31(4): 415-419,424.
[7]	邓盟齐霞徐欣周学东. 人体口腔微生物宏基因组的研究进展[J]. 华西口腔医学杂志, 2013, 31(1): 107-111.
[8]	郑义马宁胡小燕张莉. 伴放线放线杆菌对2型糖尿病患者多形核白细胞分泌白细胞介素-6和凋亡的影响[J]. 华西口腔医学杂志, 2011, 29(03): 286-288.
[9]	马丽张建全潘亚萍. 福赛斯坦纳菌在2型糖尿病患者龈下菌斑中的分布[J]. 华西口腔医学杂志, 2011, 29(01): 57-61.
[10]	周学东施文元. 人体口腔微生物组群与牙菌斑生物膜[J]. 华西口腔医学杂志, 2010, 28(02): 115-118.
[11]	陶人川陈波李雅灵马飞. 2型糖尿病患者罹患口腔假丝酵母菌感染危险因素的Logistic回归分析[J]. 华西口腔医学杂志, 2010, 28(01): 41-44.
[12]	谷宇新;李庆星;由彦玲;刘广顺;韩旭. 牙周炎对2型糖尿病患者血清C反应蛋白水平的影响[J]. 华西口腔医学杂志, 2006, 24(05): 435-437.